The article Algernon Partners with Yale University for DMT Phase 2 Depression Trial was originally published on Microdose. For more information on Algernon...
The article Beckley Psytech Acquires Eleusis Therapeutics was originally published on Microdose. Beckley Psytech Strengthens Pipeline and Development...
Canadian clinical stage drug development company, Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF), has entered an investigator-initiated clinical...
Privately-owned psychedelic medicine company Beckley Psytech Limited is buying Eleusis Therapeutics Limited in an all-stock transaction. By acquiring Eleusis,...
Psychedelic medicines company Beckley Psytech has reached an agreement to acquire its rival Eleusis Therapeutics, in alignment with The post Consolidation...
This month, Alberta, Canada joined the likes of Oregon and (maybe) Colorado in defying federal law to bring much-needed psychedelic treatment to their...
MindMed saw several management changes over the last nine months. The post MindMed Mess Results in Stock Price Roller Coaster appeared first on Green Market...
The article Psychedelics and Religious Liberty in the United States was originally published on Microdose. As we all grapple with the ongoing pandemic,...
County voters will decide in November whether to ban psilocybin services. The post Silo Wellness Looks to Open Ranch Retreat as Oregonians Vote on Psilocybin...
The article Microdose Announces Algernon Pharmaceuticals as Wonderland 2022 Headline Sponsor was originally published on Microdose. The leader in the...